Abstract
Levodopa delivery from controlled-release polymer matrix: delivery of more than 600 days in vitro and 225 days of elevated plasma levels after subcutaneous implantation in rats.
B A Sabel, P Dominiak, W Häuser, M J During and A Freese
Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 914-922;